15,009 Shares in ASP Isotopes Inc. (NASDAQ:ASPI) Bought by B. Riley Wealth Advisors Inc.

B. Riley Wealth Advisors Inc. purchased a new stake in ASP Isotopes Inc. (NASDAQ:ASPI) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 15,009 shares of the company’s stock, valued at approximately $42,000.

Other hedge funds have also added to or reduced their stakes in the company. Bank of New York Mellon Corp purchased a new position in shares of ASP Isotopes during the second quarter valued at about $381,000. Fielder Capital Group LLC purchased a new position in shares of ASP Isotopes in the 2nd quarter valued at approximately $55,000. Rhumbline Advisers purchased a new position in shares of ASP Isotopes in the 2nd quarter valued at approximately $116,000. Rathbones Group PLC boosted its position in shares of ASP Isotopes by 27.5% during the second quarter. Rathbones Group PLC now owns 195,915 shares of the company’s stock valued at $600,000 after purchasing an additional 42,243 shares in the last quarter. Finally, Renaissance Technologies LLC grew its stake in ASP Isotopes by 5.7% in the second quarter. Renaissance Technologies LLC now owns 171,800 shares of the company’s stock worth $526,000 after purchasing an additional 9,200 shares during the period. 16.80% of the stock is owned by hedge funds and other institutional investors.

ASP Isotopes Stock Up 12.4 %

Shares of NASDAQ:ASPI opened at $4.89 on Monday. The company has a current ratio of 7.55, a quick ratio of 7.54 and a debt-to-equity ratio of 0.80. The stock has a fifty day simple moving average of $5.83 and a two-hundred day simple moving average of $3.90. ASP Isotopes Inc. has a 12-month low of $1.65 and a 12-month high of $9.33. The stock has a market capitalization of $349.10 million, a price-to-earnings ratio of -8.02 and a beta of 3.27.

Analyst Ratings Changes

Several equities analysts have commented on the company. Canaccord Genuity Group assumed coverage on ASP Isotopes in a research report on Friday, October 4th. They set a “buy” rating and a $4.50 price objective for the company. Canaccord Genuity Group reissued a “buy” rating and set a $4.50 price objective on shares of ASP Isotopes in a research note on Friday, October 18th.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.